As of 2026-03-30, the Relative Valuation of Poseida Therapeutics, Inc. (PSTX) is (12.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.50 USD, the upside of Poseida Therapeutics, Inc. based on Relative Valuation is -229.9%.
The range of the Relative Valuation is (11.36) - (13.18) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 22.5x | 19.6x |
| Forward P/E multiples | 17.4x - 21.1x | 20.0x |
| Fair Price | (11.36) - (13.18) | (12.34) |
| Upside | -219.6% - -238.7% | -229.9% |
| Date | P/E |